--- title: Profil explores opportunities for artificial pancreas in type 2 diabetes description: People with diabetes perceive a high need for the availability of Artificial Pancreas systems (APS) for automated insulin delivery in diabetes care. Merging the best of different innovation cultures may contribute to a wider and more rapid implementation of user-centered APS in diabetes care. image: https://blog.profil.com/hubfs/ehealth.jpg --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg") # Profil explores opportunities for artificial pancreas in type 2 diabetes ![Prof.](https://blog.profil.com/hubfs/BLUE_MOON/content-bilder/Mitarbeiter/Driving_Innovtion_Mitarbeiter.png) Posted by [Prof. Dr. Freimut Schliess](https://blog.profil.com/blog/author/prof-dr-freimut-schliess) on Oct 2, 2018 5:18:00 PM ![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.") ![Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.") ### Highlighting the role of open and trans-sectoral collaboration in the advancement of artificial pancreas solutions Profil has recently published a peer-reviewed article on the topic of “Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project ” in the *Journal of Diabetes Science and Technology.* Profil is the organisation coordinating CLOSE. The article is authored by CLOSE industry and academic partners, representatives of the EIT Health public-private partnership management boards, and key opinion leaders in the field. ![ehealth](https://blog.profil.com/hs-fs/hubfs/ehealth.jpg?width=520&name=ehealth.jpg)**Figure 1**: ehealth [[Designed by Creativeart / Freepik](http://www.freepik.com)] The paper makes a  contribution to the recent discussion on the possible roles of artificial pancreas systems in type 2 diabetes care.  The paper explains the CLOSE approach to matching the diversity of people with type 2 diabetes and their care environments. The trans-sectoral architecture of the CLOSE partnership, the curation of the project as part of the EIT Health innovation portfolio, and the integrated advancement of technology, education, and business creation are considered key factors for the success of CLOSE. Beyond its unique capabilities in the clinical evaluation of diabetes technologies Profil contributes years of experience with coordinating the large European AP@home consortium and developing a CE-marked medical product that uses a glucose clamp technology (ClampArt®) in a closed-loop setting. The complete article “Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project” can be downloaded [here](http://journals.sagepub.com/doi/10.1177/1932296818803588). CLOSE (Automated Glucose Control at Home for People with Chronic Disease) [[1](http://eit-health.de/activities/innovation-projects/close-diabetes/)] stands for a project designed to overcome artificial pancreas (AP) implementation barriers. The primary objective of the project is to develop superior risk-benefit and cost-benefit scenarios for AP operation thereby achieving a positive acceptance by users and caregivers and a high eligibility for reimbursement. In order to meet this objective the project will put the AP into the center of comprehensive product and service packages (APplus) specifically tailored to defined T2D patient groups and care environments. In the design of APplus solutions the project is going to realize an interactive collaboration with users, healthcare providers and other stakeholders in diabetes care. In a first step CLOSE will establish a scalable APplus model case working at the interface between patients, homecare service providers, and payers in France. CLOSE will then scale up APplus by pursuing geographic distribution, targeting additional audiences and by enhancing AP functionalities and interconnectedness.   Topics: [The Science behind Diabetes](https://blog.profil.com/blog/topic/the-science-behind-diabetes), [Treating Diabetes](https://blog.profil.com/blog/topic/treating-diabetes), [Diabetes Technology](https://blog.profil.com/blog/topic/diabetes-technology) [Leave a comment](https://blog.profil.com/blog/profil-explores-opportunities-for-artificial-pancreas-in-type-2-diabetes#comment_form) ### Subscribe to Email Updates ### Our most popular Posts ### Posts by Topic - [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes) - [About Profil (69)](https://blog.profil.com/blog/topic/about-profil) - [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods) - [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes) - [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes) - [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology) - [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity) - [Events (4)](https://blog.profil.com/blog/topic/events) - [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection) - [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs) [see all](https://blog.profil.com/blog/profil-explores-opportunities-for-artificial-pancreas-in-type-2-diabetes#) ## You might also like this post ### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)